# concept[].display
Central line including umbilical catheter

# concept[].display
Infection present at time of surgery (PATOS)

# concept[].display
Surgical site infection (SSI) detected using the NHSN ICD-code based admit and readmit SSI surveillance toolkit

# concept[].display
Revision associated with prior infection at index joint

# concept[].display
Report No Events: Infection Surveillance: MSSA

# concept[].display
Report No Events: LabID Event (All specimens): MSSA

# concept[].display
Report No Events: LabID Event (Blood specimens only): MSSA

# concept[].display
Active surgical site infection (SSI) detection method

# concept[].display
Passive surgical site infection (SSI) detection method

# concept[].display
Report No Events: NICU: PedVAE: birth weight under 750 grams

# concept[].display
Report No Events: NICU: PedVAE: birth weight 751-1000 grams

# concept[].display
Report No Events: NICU: PedVAE: birth weight 1001-1500 grams

# concept[].display
Report No Events: NICU: PedVAE: birth weight 1501-2500 grams

# concept[].display
Report No Events: NICU: PedVAE: birth weight over 2500 grams

# concept[].display
Report No Events: NICU: PedVAE: Extremely preterm (<28 weeks)

# concept[].display
Cooperative infection prevention process between facilities

# concept[].display
Patient or caregiver contacts facility to report

# concept[].display
Patient returns to outpatient facility for follow-up

# concept[].display
Report from another facility (inpatient, health department, emergency department, etc.)

# concept[].display
Report No Events: NICU: PedVAE: Very preterm (28 to <32 weeks)

# concept[].display
Report No Events: NICU: PedVAE: Moderate to late preterm (32 to <37 weeks)

# concept[].display
Report No Events: NICU: PedVAE: Term (>=37 weeks)

# concept[].display
Number of episodes of mechanical ventilation (EMV) days

# concept[].display
Moderate to late preterm (32 to <37 weeks)

# concept[].display
Report No Events: Same Day Outcome Measures

# concept[].display
Report No Events: Antimicrobial Resistance (AR)

# concept[].display
New Antibiotic Starts for UTI Indication

# concept[].display
Number of units transfused: Cryoprecipitate: Pathogen Reduced Cryoprecipitated Fibrinogen Complex

# concept[].display
Number of discards: Cryoprecipitate: Pathogen Reduced Cryoprecipitated Fibrinogen Complex

# concept[].display
Number of admissions on C. difficile treatment

# concept[].display
Resident transferred from acute care facility in past 4 weeks

# concept[].display
Resident on antibiotic therapy for this specific organism at the time of transfer

# concept[].display
Admission (during the stay in which the surgery was performed)

# concept[].display
Readmission to facility where procedure was performed

# concept[].display
Readmission to facility other than where procedure was performed

# concept[].display
Deep incisional primary surgical site infection (SSI)

# concept[].display
Deep incisional secondary surgical site infection (SSI)

# concept[].display
Ear or mastoid infection (otitis externa, otitis media, otitis interna, mastoiditis)

# concept[].display
Eye infection, other than conjunctivitis

# concept[].display
Gastrointestinal tract infection (esophagus, stomach, small and large bowel, and rectum) excluding gastroenteritis and appendicitis

# concept[].display
Intraabdominal infection, not specified elsewhere including gallbladder, bile ducts, liver (excluding viral hepatitis), spleen, pancreas, peritoneum, subphrenic or subdiaphragmatic space, or other intraabdominal tissue or area not specified elsewhere

# concept[].display
Intracranial infection (brain abscess, subdural or epidural infection, encephalitis)

# concept[].display
Other infections of lower respiratory tract, other than pneumonia

# concept[].display
Oral cavity infection (mouth, tongue, or gums)

# concept[].display
Other infections of the male or female reproductive tract (epididymis, testes, prostate, vagina, ovaries, uterus, or other deep pelvic tissues, excluding endometritis or vaginal cuff infections)

# concept[].display
Other infections of the urinary tract (kidney, ureter, bladder, urethra, or tissue surrounding the retroperitoneal or perinephric space)

# concept[].display
Superficial incisional primary surgical site infection (SSI)

# concept[].display
Superficial incisional secondary surgical site infection (SSI)

# concept[].display
Upper respiratory tract infection, pharyngitis, laryngitis, epiglottitis

# concept[].display
Number of admissions with an order for a prophylactic intravenous antibiotic that was administered on time

# concept[].display
Number of admissions with an order for a prophylactic intravenous antibiotic that was not administered on time

# concept[].display
Number of admissions with no order for a prophylactic intravenous antibiotic

# concept[].display
Total number of admissions with a primary CPT code in this procedure category

# concept[].display
Order for prophylactic intravenous antibiotic not administered on time

# concept[].display
Routine follow-up at outpatient facility

# concept[].display
Summary data reporting outpatient procedure component events at a facility

# concept[].display
Soft tissue, muscle, lymph node, or salivary gland infection

# concept[].display
Multi-drug resistant organism (MDRO) infection

# concept[].display
C. difficile-associated disease (CDAD) infection

# concept[].display
Infection of the ear, eyes, nose, or throat

# concept[].display
Number of new episodes of mechanical ventilation (EMV)

# concept[].display
Number of patient days adjusted for MDRO reporting (for inpatient location)

# concept[].display
Number of admissions adjusted for MDRO reporting (for inpatient location)

# concept[].display
Number of encounters adjusted for MDRO reporting

# concept[].display
Number of patient days adjusted for C. difficile reporting (for inpatient location)

# concept[].display
Number of admissions adjusted for C. difficile reporting

# concept[].display
Number of encounters adjusted for C. difficile reporting

# concept[].display
Number of airway pressure release ventilation (APRV) days

# concept[].display
Number of central line days including umbilical catheter

# concept[].display
Number of patients meeting high risk criteria for influenza vaccination

# concept[].display
Number of patients previously vaccinated for influenza during current influenza season

# concept[].display
Number of patients meeting high risk criteria and previously vaccinated for influenza during current influenza season

# concept[].display
Number of patients meeting high risk criteria for influenza vaccination and offered influenza vaccination but declining for reasons other than medical contraindication

# concept[].display
Number of patients meeting high risk criteria and offered influenza vaccination but declining because of having medical contraindication

# concept[].display
Number of patients meeting high risk criteria and receiving vaccination during admission

# concept[].display
Number of observations in which hand hygiene was indicated

# concept[].display
Number of observations in which hand hygiene was performed

# concept[].display
Number of observations in which the use of gown and gloves was indicated

# concept[].display
Number of observations in which gown and gloves were used

# concept[].display
Timing of active surveillance testing (AST)

# concept[].display
Active surveillance testing (AST) eligible patients

# concept[].display
Number of patients eligible for monitoring at admission/transfer in

# concept[].display
Number of patients on which monitoring was performed at admission/transfer in

# concept[].display
Number of patients eligible for monitoring at discharge/transfer out

# concept[].display
Number of patients on which monitoring was performed at discharge/transfer out

# concept[].display
Number of prevalent cases identified by monitoring (clinical positive)

# concept[].display
Number of prevalent cases previously known

# concept[].display
Number of incident cases identified by monitoring (clinical positive)

# concept[].display
Summary data reporting catheter and ventilator use in a ICU/other

# concept[].display
Summary data reporting catheter and ventilator use in a SCA

# concept[].display
Summary data reporting catheter and ventilator use in a NICU

# concept[].display
Summary data reporting active surveillance testing (AST)

# concept[].display
Summary data reporting antimicrobial usage

# concept[].display
Number of total facility patient days (for inpatient location)

# concept[].display
Number of total facility admissions (for inpatient location)

# concept[].display
Number of total facility encounters (for outpatient location)

# concept[].display
Summary data reporting MDRO and CDI LabID Event for LTCF

# concept[].display
Blood culture not done or no organisms detected in blood

# concept[].display
New onset/worsening cough, dyspnea, tachypnea

# concept[].display
New onset or change in sputum, increased secretions or increased suctioning

# concept[].display
Occult or gross blood in stools (with no rectal fissure)

# concept[].display
Greater than or equal to 5% bronchoalveolar lavage cells with bacteria

# concept[].display
New or progressive and persistent infiltrate

# concept[].display
One positive culture with >=100,000 cfu/ml with no more than 2 species of microorganisms

# concept[].display
Positive dipstick for leukocyte esterase or nitrate

# concept[].display
Greater than or equal to 2 positive urine cultures with >=100 cfu/ml of same uropathogen from non-voided specimen

# concept[].display
One positive culture with <=100,000 cfu/ml of a single uropathogen in patient being treated with an effective antimicrobial agent for UTI

# concept[].display
Greater than or equal to 2 positive urine cultures with >=100,000 cfu/ml with no more than 2 organisms

# concept[].display
Positive detection of viral antigen or antibody

# concept[].display
Fourfold rise in paired sera for pathogen

# concept[].display
Positive culture or microimmunofluorescence of Legionella species

# concept[].display
Legionella pneumophila serogroup 1 antigens in urine

# concept[].display
Fourfold rise in Legionella pneumophila antibody titer

# concept[].display
Matching positive blood and sputum cultures with Candida species

# concept[].display
Fungi or Pneumocystis carinii from lower respiratory tract specimen

# concept[].display
More than 15 colonies cultured from intravascular cannula tip using semi-quantitative culture method

# concept[].display
Positive Gram stain when culture is negative or not done

# concept[].display
Common commensal from >=2 blood cultures

# concept[].display
Organism(s) identified from pleural fluid

# concept[].display
Positive quantitative culture from lower respiratory tract (LRT) specimen

# concept[].display
Positive PCR for Chlamydia or Mycoplasma

# concept[].display
Recognized pathogen from one or more blood cultures

# concept[].display
Histopathologic exam with abscess formation or lung parenchyma invasion by fungal hyphae

# concept[].display
Acute onset of diarrhea (liquid stools for >12 hours)

# concept[].display
Apnea, tachypnea, nasal flaring with retraction of chest wall or grunting

# concept[].display
Allogeneic hematopoietic stem cell transplant (allo-SCT) with grade >=3 gastrointestinal graft-versus-host disease (GI GVHD)

# concept[].display
Allogeneic hematopoietic stem cell transplant (allo-SCT) with diarrhea

# concept[].display
Positive culture from >=2 separate tissue or fluid samples from affected joint

# concept[].display
Acute pain, swelling, or tenderness of testes, epididymis, or prostate

# concept[].display
C. difficile primary testing method used most often for this quarter

# concept[].display
Glutamate dehydrogenase (GDH) antigen plus enzyme immunoassay (EIA) for toxin

# concept[].display
Glutamate dehydrogenase (GDH) plus nucleic acid amplification test (NAAT)

# concept[].display
Glutamate dehydrogenase (GDH) plus enzyme immunoassay (EIA) for toxin, followed by nucleic acid amplification test (NAAT) for discrepant results

# concept[].display
Bacterial isolate tested for carbapenemase

# concept[].display
Isolate tested positive for carbapenemase

# concept[].display
Nucleic acid amplification test (NAAT) plus enzyme immunoassay (EIA), if NAAT positive (2-step algorithm)

# concept[].display
Coronary artery bypass graft with both chest and donor site incisions

# concept[].display
Coronary artery bypass graft with chest incision only

# concept[].display
Only patients with no prior documentation of colonization or infection

# concept[].display
Intravenous injection of antifungal substance

# concept[].display
Imputability of positive blood culture to suspected source

# concept[].display
Number of chronic hemodialysis patients: fistula

# concept[].display
Number of fistula patients who undergo buttonhole cannulation

# concept[].display
Number of chronic hemodialysis patients: graft

# concept[].display
Number of chronic hemodialysis patients: tunneled central line

# concept[].display
Number of chronic hemodialysis patients: non-tunneled central line

# concept[].display
Number of chronic hemodialysis patients: other access device

# concept[].display
Summary data reporting vascular access types for chronic hemodialysis patients

# concept[].display
Wound (not related to vascular access) with pus or increased redness

# concept[].display
Site of non-tunneled central line, dialysis

# concept[].display
Where was the positive blood culture collected

# concept[].display
Hospital (on the day of or the day following admission) or Emergency Department

# concept[].display
New outpatient start or continuation of inpatient course

# concept[].display
Location of mechanical ventilation initiation

# concept[].display
Patient on airway pressure release ventilation (APRV) or a related mode of mechanical ventilation at the time of VAE

# concept[].display
Daily minimum FiO2 increase >=0.20 (20 points) for >=2 days

# concept[].display
Daily minimum PEEP increase >=3 cm H2O for >=2 days

# concept[].display
White blood cell count >=12,000 or <=4,000 cells/mm3

# concept[].display
A new antimicrobial agent(s) is started, and is continued for >=4 days

# concept[].display
Criterion 1: positive culture from endotracheal aspirate without purulent respiratory secretions

# concept[].display
Criterion 1: positive culture from bronchoalveolar lavage without purulent respiratory secretions

# concept[].display
Criterion 1: positive culture from lung tissue without purulent respiratory secretions

# concept[].display
Criterion 1: positive culture from protected specimen brush without purulent respiratory secretions

# concept[].display
Criterion 2: purulent respiratory secretions plus organism(s)

# concept[].display
Criterion 2: organisms from sputum culture with purulent respiratory secretions

# concept[].display
Criterion 2: organisms from endotracheal aspirate culture with purulent respiratory secretions

# concept[].display
Criterion 2: organisms from bronchoalveolar lavage culture with purulent respiratory secretions

# concept[].display
Criterion 2: organisms from lung tissue culture with purulent respiratory secretions

# concept[].display
Criterion 2: organisms from protected specimen brush culture with purulent respiratory secretions

# concept[].display
Criterion 3: positive test for organism(s) identified from pleural fluid

# concept[].display
Criterion 3: positive test for lung histopathology

# concept[].display
Criterion 3: positive diagnostic test for Legionella species

# concept[].display
Criterion 3: positive diagnostic test for selected viral pathogens

# concept[].display
Licensed independent practitioners: physicians, advanced practice nurses, and physician assistants

# concept[].display
Adult students or trainees and volunteers

# concept[].display
One positive culture with >=1,000 cfu/ml and <100,000 cfu/ml with no more than 2 species of microorganisms

# concept[].display
Summary data reporting antimicrobial resistance patterns at a facility

# concept[].display
Blood product was implicated in the adverse reaction

# concept[].display
Imputability of adverse reaction to transfusion

# concept[].display
Received non-irradiated blood in the 2 months preceding the reaction

# concept[].display
Hemovigilance module - monthly reporting denominator

# concept[].display
Last physical overnight location of patient immediately prior to arriving into facility

# concept[].display
Patient discharged from another facility in the past 4 weeks

# concept[].display
Other inpatient healthcare setting (e.g., Acute Care Hospital, LTAC, Rehabilitation, etc.)

# concept[].display
Report No Events: NICU: CLABSI: under 750 grams

# concept[].display
Report No Events: NICU: CLABSI: 751-1000 grams

# concept[].display
Report No Events: NICU: CLABSI: 1001-1500 grams

# concept[].display
Report No Events: NICU: CLABSI: 1501-2500 grams

# concept[].display
Report No Events: NICU: CLABSI: over 2500 grams

# concept[].display
Report No Events: NICU: PedVAP: under 750 grams

# concept[].display
Report No Events: NICU: PedVAP: 751-1000 grams

# concept[].display
Report No Events: NICU: PedVAP: 1001-1500 grams

# concept[].display
Report No Events: NICU: PedVAP: 1501-2500 grams

# concept[].display
Report No Events: NICU: PedVAP: over 2500 grams

# concept[].display
Report No Events: Infection Surveillance: MRSA

# concept[].display
Report No Events: LabID Event (All specimens): MRSA

# concept[].display
Report No Events: LabID Event (Blood specimens only): MRSA

# concept[].display
Report No Events: Infection Surveillance: VRE

# concept[].display
Report No Events: LabID Event (All specimens): VRE

# concept[].display
Report No Events: LabID Event (Blood specimens only): VRE

# concept[].display
Report No Events: Infection Surveillance: CephR Klebsiella

# concept[].display
Report No Events: LabID Event (All specimens): CephR Klebsiella

# concept[].display
Report No Events: LabID Event (Blood specimens only): CephR Klebsiella

# concept[].display
Report No Events: Infection Surveillance: CRE-E. coli

# concept[].display
Report No Events: LabID Event (All specimens): CRE-E. coli

# concept[].display
Report No Events: LabID Event (Blood specimens only): CRE-E. coli

# concept[].display
Report No Events: Infection Surveillance: CRE-Enterobacter

# concept[].display
Report No Events: LabID Event (All specimens): CRE-Enterobacter

# concept[].display
Report No Events: LabID Event (Blood specimens only): CRE-Enterobacter

# concept[].display
Report No Events: Infection Surveillance: CRE-Klebsiella

# concept[].display
Report No Events: LabID Event (All specimens): CRE-Klebsiella

# concept[].display
Report No Events: LabID Event (Blood specimens only): CRE-Klebsiella

# concept[].display
Report No Events: Infection Surveillance: MDR-Acinetobacter

# concept[].display
Report No Events: LabID Event (All specimens): MDR-Acinetobacter

# concept[].display
Report No Events: LabID Event (Blood specimens only): MDR-Acinetobacter

# concept[].display
Report No Events: Infection Surveillance: C. difficile

# concept[].display
Report No Events: LabID Event (All specimens): C. difficile

# concept[].display
Report No Events: Dialysis: intravenous antimicrobial start

# concept[].display
Report No Events: Dialysis: positive blood culture

# concept[].display
Report No Events: Dialysis: pus, redness, or increased swelling at vascular access site

# concept[].display
Known or suspected Munchausen syndrome by proxy during current admission

# concept[].display
Observed or suspected patient injection into vascular line(s) within the BSI infection window

# concept[].display
Epidermolysis bullosa during current admission

# concept[].display
Pus present at vascular specimen collection site and matching organism identified in blood and from site-specific specimen(s)

# concept[].display
Peripheral intravenous or midline catheter

# concept[].display
Hemodialysis reliable outflow (HERO) catheter

# concept[].display
Non-accessed central line (not accessed nor inserted during the hospitalization)

# concept[].display
Neonatal Laboratory Confirmed Bloodstream Infection 1 (NLCBI 1)

# concept[].display
Neonatal Laboratory Confirmed Bloodstream Infection 2 (NLCBI 2)

# concept[].display
Neonatal Laboratory Confirmed Meningitis 1 (NLCM 1)

# concept[].display
Neonatal Laboratory Confirmed Meningitis 2 (NLCM 2)

# concept[].display
Common commensal from blood specimen(s) and antibiotics for >=5 days

# concept[].display
Recognized pathogen from cerebrospinal fluid specimen

# concept[].display
Common commensal from cerebrospinal fluid specimen and antibiotics for >=5 days

# concept[].display
Peripherally inserted central catheter (PICC)

# concept[].display
Active surveillance testing (AST) organism monitored

# concept[].display
Total number of units transfused: Red Blood Cells: Whole blood-derived

# concept[].display
Total number of aliquots transfused: Red Blood Cells: Whole blood-derived

# concept[].display
Number of units transfused: Red Blood Cells: Whole blood-derived: Irradiated

# concept[].display
Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Irradiated

# concept[].display
Number of units transfused: Red Blood Cells: Whole blood-derived: Leukocyte-reduced

# concept[].display
Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Leukocyte-reduced

# concept[].display
Number of units transfused: Red Blood Cells: Whole blood-derived: Irradiated and leukocyte-reduced

# concept[].display
Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Irradiated and leukocyte-reduced

# concept[].display
Total number of units transfused: Red Blood Cells: Apheresis

# concept[].display
Total number of aliquots transfused: Red Blood Cells: Apheresis

# concept[].display
Number of units transfused: Red Blood Cells: Apheresis: Irradiated

# concept[].display
Number of aliquots transfused: Red Blood Cells: Apheresis: Irradiated

# concept[].display
Number of units transfused: Red Blood Cells: Apheresis: Leukocyte-reduced

# concept[].display
Number of aliquots transfused: Red Blood Cells: Apheresis: Leukocyte-reduced

# concept[].display
Number of units transfused: Red Blood Cells: Apheresis: Irradiated or leukocyte-reduced

# concept[].display
Number of aliquots transfused: Red Blood Cells: Apheresis: Irradiated or leukocyte-reduced

# concept[].display
Total number of units transfused: Platelets: Whole blood-derived

# concept[].display
Number of units transfused: Platelets: Whole blood-derived: Irradiated

# concept[].display
Number of units transfused: Platelets: Whole blood-derived: Leukocyte-reduced

# concept[].display
Number of units transfused: Platelets: Whole blood-derived: Irradiated and leukocyte-reduced

# concept[].display
Total number of units transfused: Platelets: Apheresis

# concept[].display
Total number of aliquots transfused: Platelets: Apheresis

# concept[].display
Number of units transfused: Platelets: Apheresis: Irradiated

# concept[].display
Number of aliquots transfused: Platelets: Apheresis: Irradiated

# concept[].display
Number of units transfused: Platelets: Apheresis: Leukocyte-reduced

# concept[].display
Number of aliquots transfused: Platelets: Apheresis: Leukocyte-reduced

# concept[].display
Number of units transfused: Platelets: Apheresis: Irradiated or leukocyte-reduced

# concept[].display
Number of aliquots transfused: Platelets: Apheresis: Irradiated or leukocyte-reduced

# concept[].display
Total number of units transfused: Plasma: Whole blood-derived

# concept[].display
Total number of aliquots transfused: Plasma: Whole blood-derived

# concept[].display
Total number of units transfused: Plasma: Apheresis

# concept[].display
Total number of aliquots transfused: Plasma: Apheresis

# concept[].display
Total number of units transfused: Cryoprecipitate

# concept[].display
Number of patient samples collected for type and screen or crossmatch

# concept[].display
Total number of units transfused: Whole Blood

# concept[].display
Total number of aliquots transfused: Whole Blood

# concept[].display
Total number of discards: Red Blood Cells: Whole blood-derived

# concept[].display
Number of units transfused: Red Blood Cells: Whole blood-derived: Not irradiated or leukocyte-reduced

# concept[].display
Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Not irradiated or leukocyte-reduced

# concept[].display
Number of discards: Red Blood Cells: Whole blood-derived: Not irradiated or leukocyte-reduced

# concept[].display
Number of discards: Red Blood Cells: Whole blood-derived: Irradiated

# concept[].display
Number of discards: Red Blood Cells: Whole blood-derived: Leukocyte-reduced

# concept[].display
Number of discards: Red Blood Cells: Whole blood-derived: Irradiated and leukocyte-reduced

# concept[].display
Total number of discards: Red Blood Cells: Apheresis

# concept[].display
Number of units transfused: Red Blood Cells: Apheresis: Not irradiated or leukocyte-reduced

# concept[].display
Number of aliquots transfused: Red Blood Cells: Apheresis: Not irradiated or leukocyte-reduced

# concept[].display
Number of discards: Red Blood Cells: Apheresis: Not irradiated or leukocyte-reduced

# concept[].display
Number of discards: Red Blood Cells: Apheresis: Irradiated

# concept[].display
Number of discards: Red Blood Cells: Apheresis: Leukocyte-reduced

# concept[].display
Number of discards: Red Blood Cells: Apheresis: Irradiated or leukocyte-reduced

# concept[].display
Total number of discards: Platelets: Whole blood-derived

# concept[].display
Number of units transfused: Platelets: Whole blood-derived: Not irradiated or leukocyte-reduced

# concept[].display
Number of discards: Platelets: Whole blood-derived: Not irradiated or leukocyte-reduced

# concept[].display
Number of discards: Platelets: Whole blood-derived: Irradiated

# concept[].display
Number of discards: Platelets: Whole blood-derived: Leukocyte-reduced

# concept[].display
Number of discards: Platelets: Whole blood-derived: Irradiated and leukocyte-reduced

# concept[].display
Total number of discards: Platelets: Apheresis

# concept[].display
Number of units transfused: Platelets: Apheresis: Not irradiated or leukocyte-reduced

# concept[].display
Number of aliquots transfused: Platelets: Apheresis: Not irradiated or leukocyte-reduced

# concept[].display
Number of discards: Platelets: Apheresis: Not irradiated or leukocyte-reduced

# concept[].display
Number of discards: Platelets: Apheresis: Irradiated

# concept[].display
Number of discards: Platelets: Apheresis: Leukocyte-reduced

# concept[].display
Number of discards: Platelets: Apheresis: Irradiated or leukocyte-reduced

# concept[].display
Total number of discards: Plasma: Whole blood-derived

# concept[].display
Total number of discards: Plasma: Apheresis

# concept[].display
Total number of discards: Cryoprecipitate

# concept[].display
Total number of units transfused: Platelets: Whole blood-derived: Psoralen- and Riboflavin-treated

# concept[].display
Total number of discards: Platelets: Whole blood-derived: Psoralen- and Riboflavin-treated

# concept[].display
Number of units transfused: Platelets: Whole blood-derived: Psoralen-treated

# concept[].display
Number of discards: Platelets: Whole blood-derived: Psoralen-treated

# concept[].display
Number of units transfused: Platelets: Whole blood-derived: Riboflavin-treated

# concept[].display
Number of discards: Platelets: Whole blood-derived: Riboflavin-treated

# concept[].display
Total number of units transfused: Platelets: Apheresis: Psoralen- and Riboflavin-treated

# concept[].display
Total number of aliquots transfused: Platelets: Apheresis: Psoralen- and Riboflavin-treated

# concept[].display
Total number of discards: Platelets: Apheresis: Psoralen- and Riboflavin-treated

# concept[].display
Number of units transfused: Platelets: Apheresis: Psoralen-treated

# concept[].display
Number of aliquots transfused: Platelets: Apheresis: Psoralen-treated

# concept[].display
Number of discards: Platelets: Apheresis: Psoralen-treated

# concept[].display
Number of units transfused: Platelets: Apheresis: Riboflavin-treated

# concept[].display
Number of aliquots transfused: Platelets: Apheresis: Riboflavin-treated

# concept[].display
Number of discards: Platelets: Apheresis: Riboflavin-treated

# concept[].display
Total number of units transfused: Plasma: Whole blood-derived: Psoralen- and Riboflavin-treated

# concept[].display
Total number of aliquots transfused: Plasma: Whole blood-derived: Psoralen- and Riboflavin-treated

# concept[].display
Total number of discards: Plasma: Whole blood-derived: Psoralen- and Riboflavin-treated

# concept[].display
Number of units transfused: Plasma: Whole blood-derived: Psoralen-treated

# concept[].display
Number of aliquots transfused: Plasma: Whole blood-derived: Psoralen-treated

# concept[].display
Number of discards: Plasma: Whole blood-derived: Psoralen-treated

# concept[].display
Number of units transfused: Plasma: Whole blood-derived: Riboflavin-treated

# concept[].display
Number of aliquots transfused: Plasma: Whole blood-derived: Riboflavin-treated

# concept[].display
Number of discards: Plasma: Whole blood-derived: Riboflavin-treated

# concept[].display
Total number of units transfused: Plasma: Apheresis: Psoralen- and Riboflavin-treated

# concept[].display
Total number of aliquots transfused: Plasma: Apheresis: Psoralen- and Riboflavin-treated

# concept[].display
Total number of discards: Plasma: Apheresis: Psoralen- and Riboflavin-treated

# concept[].display
Number of units transfused: Plasma: Apheresis: Psoralen-treated

# concept[].display
Number of aliquots transfused: Plasma: Apheresis: Psoralen-treated

# concept[].display
Number of discards: Plasma: Apheresis: Psoralen-treated

# concept[].display
Number of units transfused: Plasma: Apheresis: Riboflavin-treated

# concept[].display
Number of aliquots transfused: Plasma: Apheresis: Riboflavin-treated

# concept[].display
Number of discards: Plasma: Apheresis: Riboflavin-treated

# concept[].display
No hemovigilance adverse reactions reported this month

# concept[].display
No hemovigilance incidents reported this month

# concept[].display
Facility transfuses blood products treated with pathogen reduction technology

# concept[].display
Total number of units transfused: Red Blood Cells: Whole blood-derived: S-303- and Riboflavin-treated

# concept[].display
Total number of aliquots transfused: Red Blood Cells: Whole blood-derived: S-303- and Riboflavin-treated

# concept[].display
Total number of discards: Red Blood Cells: Whole blood-derived: S-303- and Riboflavin-treated

# concept[].display
Number of units transfused: Red Blood Cells: Whole blood-derived: S-303-treated

# concept[].display
Number of aliquots transfused: Red Blood Cells: Whole blood-derived: S-303-treated

# concept[].display
Number of discards: Red Blood Cells: Whole blood-derived: S-303-treated

# concept[].display
Number of units transfused: Red Blood Cells: Whole blood-derived: Riboflavin-treated

# concept[].display
Number of aliquots transfused: Red Blood Cells: Whole blood-derived: Riboflavin-treated

# concept[].display
Number of discards: Red Blood Cells: Whole blood-derived: Riboflavin-treated

# concept[].display
Total number of units transfused: Red Blood Cells: Apheresis: S-303- and Riboflavin-treated

# concept[].display
Total number of aliquots transfused: Red Blood Cells: Apheresis: S-303- and Riboflavin-treated

# concept[].display
Total number of discards: Red Blood Cells: Apheresis: S-303- and Riboflavin-treated

# concept[].display
Number of units transfused: Red Blood Cells: Apheresis: S-303-treated

# concept[].display
Number of aliquots transfused: Red Blood Cells: Apheresis: S-303-treated

# concept[].display
Number of discards: Red Blood Cells: Apheresis: S-303-treated

# concept[].display
Number of units transfused: Red Blood Cells: Apheresis: Riboflavin-treated

# concept[].display
Number of aliquots transfused: Red Blood Cells: Apheresis: Riboflavin-treated

# concept[].display
Number of discards: Red Blood Cells: Apheresis: Riboflavin-treated

# concept[].display
Total number of units transfused: Cryoprecipitate: Psoralen- and Riboflavin-treated

# concept[].display
Total number of discards: Cryoprecipitate: Psoralen- and Riboflavin-treated

# concept[].display
Number of units transfused: Platelets: Apheresis: Psoralen-treated and in plasma

# concept[].display
Number of aliquots transfused: Platelets: Apheresis: Psoralen-treated and in plasma

# concept[].display
Number of discards: Platelets: Apheresis: Psoralen-treated and in plasma

# concept[].display
Number of units transfused: Platelets: Apheresis: Psoralen-treated and in platelet additive solution

# concept[].display
Number of aliquots transfused: Platelets: Apheresis: Psoralen-treated and in platelet additive solution

# concept[].display
Number of discards: Platelets: Apheresis: Psoralen-treated and in platelet additive solution

# concept[].display
Number of units transfused: Platelets: Apheresis: Riboflavin-treated and in plasma

# concept[].display
Number of aliquots transfused: Platelets: Apheresis: Riboflavin-treated and in plasma

# concept[].display
Number of discards: Platelets: Apheresis: Riboflavin-treated and in plasma

# concept[].display
Number of units transfused: Platelets: Apheresis: Riboflavin-treated and in platelet additive solution

# concept[].display
Number of aliquots transfused: Platelets: Apheresis: Riboflavin-treated and in platelet additive solution

# concept[].display
Number of discards: Platelets: Apheresis: Riboflavin-treated and in platelet additive solution

# concept[].display
To address a new indication for a central line

# concept[].display
To replace an existing, malfunctioning central line

# concept[].display
To replace an existing central line where infection was suspected

# concept[].display
Patient is less than 2 months of age - chlorhexidine gluconate is to be used with caution in patients less than 2 months of age

# concept[].display
Patient has a documented/known allergy/reaction to chlorhexidine gluconate-based products that would preclude its use

# concept[].display
Facility restrictions or safety concerns for chlorhexidine gluconate use in premature infants precludes its use